Search results
F.D.A. Authorizes First Menthol-Flavored E-Cigarettes
New York Times· 4 days agoThe Food and Drug Administration said on Friday that it had approved the first menthol-flavored...
Gateway - The Root
The Root· 7 days agoIf so, you’re going to love this new announcement from the U.S. Food and Drug Administration. On Thursday, the F.D.A
Opinion | It’s Time to Ban Pharmaceutical Advertising
New York Times· 6 days agoSeeing that phrase on my screen as I idly scrolled TikTok made me stop and watch the whole video,...
COVID's side effects are still spreading. Why do Trump, Biden run from how they handled it?
The Bergen Record via Yahoo News· 3 hours agoThe vaccine skepticism of Independent presidential candidate Robert F. Kennedy Jr. is pointedly...
Meet the guy who negotiated with developers on Center City’s behalf (and once won a Tony)
Philly.com· 3 hours agoKennedy Boulevard, it represents some of the city’s most iconic locales. In recent years, Richard...
⚓ The final SOS | Morning Newsletter
Philly.com· 1 day agoAfter a federal order to leave its South Philadelphia berth, the SS United States’ options are few, its conservancy says — including being sunk or sold...
No zeros: How a new Kanas City Public Schools grading policy is meant to improve equity
Branson Tri-Lakes News· 14 hours agoKansas City Public Schools changed its grading policy beginning with the 2023-24 school year (Zach Bauman/The Beacon). The district launched a different grading system during ...
Easing federal marijuana rules: There’s still a long way to go
Kentucky Lantern via Yahoo News· 5 days agoMore than a month after the U.S. Drug Enforcement Administration proposed loosening a federal...
12 recent scientific breakthroughs
The Week via Yahoo News· 7 days agoThis means that "for every six orbits completed by planet b, the closest planet to the star, the outermost planet g completes one," CNN said, adding that...
Structural basis of tolvaptan binding to the vasopressin V2 receptor - Acta Pharmacologica Sinica
Nature· 5 days agoThe vasopressin V2 receptor (V2R) is a validated therapeutic target for autosomal dominant polycystic kidney disease (ADPKD), with tolvaptan being the first FDA-approved ...